img

Global In-Vitro Toxicity Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global In-Vitro Toxicity Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
Due to the COVID-19 pandemic, the global In-Vitro Toxicity Testing market size was US$ 9889.1 million in 2022 and is forecast to a readjusted size of US$ 17060 million by 2034 with a CAGR of 8.0% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Cell Culture Technologies accounting for % of the In-Vitro Toxicity Testing global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Pharmaceuticals & Biopharmaceuticals segment is altered to an % CAGR throughout this forecast period.
The global key companies of In-Vitro Toxicity Testing include Thermo Fisher Scientific, Covance, Bio-Rad Laboratories, GE Healthcare, Eurofins Scientific, Merck KGaA, Charles River Laboratories, Catalent and Cyprotex, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States In-Vitro Toxicity Testing market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe In-Vitro Toxicity Testing landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global In-Vitro Toxicity Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global In-Vitro Toxicity Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global In-Vitro Toxicity Testing market. Readers of the report can become informed about current and future trends of the global In-Vitro Toxicity Testing market and how they will impact market growth during the forecast period.



By Company


Thermo Fisher Scientific
Covance
Bio-Rad Laboratories
GE Healthcare
Eurofins Scientific
Merck KGaA
Charles River Laboratories
Catalent
Cyprotex
QIAGEN
Promega
Gentronix
BioIVT
MB Research Laboratories
Segment by Type
Cell Culture Technologies
High-throughput Technologies
Toxicogenomics

Segment by Application


Pharmaceuticals & Biopharmaceuticals
Cosmetic & Household Products
Food
Chemicals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of In-Vitro Toxicity Testing in global and regional level.
Chapter 3Detailed analysis of In-Vitro Toxicity Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Toxicity Testing revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Toxicity Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Cell Culture Technologies
1.2.3 High-throughput Technologies
1.2.4 Toxicogenomics
1.3 Market by Application
1.3.1 Global In-Vitro Toxicity Testing Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Pharmaceuticals & Biopharmaceuticals
1.3.3 Cosmetic & Household Products
1.3.4 Food
1.3.5 Chemicals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global In-Vitro Toxicity Testing Market Size (2018-2034)
2.2 In-Vitro Toxicity Testing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global In-Vitro Toxicity Testing Market Size by Region (2018-2024)
2.4 Global In-Vitro Toxicity Testing Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 In-Vitro Toxicity Testing Countries Ranking by Market Size
3 In-Vitro Toxicity Testing Competitive by Company
3.1 Global In-Vitro Toxicity Testing Revenue by Players
3.1.1 Global In-Vitro Toxicity Testing Revenue by Players (2018-2024)
3.1.2 Global In-Vitro Toxicity Testing Market Share by Players (2018-2024)
3.2 Global In-Vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by In-Vitro Toxicity Testing Revenue
3.4 Global In-Vitro Toxicity Testing Market Concentration Ratio
3.4.1 Global In-Vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicity Testing Revenue in 2022
3.5 Global Key Players of In-Vitro Toxicity Testing Head office and Area Served
3.6 Global Key Players of In-Vitro Toxicity Testing, Product and Application
3.7 Global Key Players of In-Vitro Toxicity Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global In-Vitro Toxicity Testing Breakdown Data by Type
4.1 Global In-Vitro Toxicity Testing Historic Revenue by Type (2018-2024)
4.2 Global In-Vitro Toxicity Testing Forecasted Revenue by Type (2024-2034)
5 Global In-Vitro Toxicity Testing Breakdown Data by Application
5.1 Global In-Vitro Toxicity Testing Historic Market Size by Application (2018-2024)
5.2 Global In-Vitro Toxicity Testing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America In-Vitro Toxicity Testing Revenue by Company (2021-2024)
6.2 North America In-Vitro Toxicity Testing Revenue by Type (2018-2034)
6.3 North America In-Vitro Toxicity Testing Revenue by Application (2018-2034)
6.4 North America In-Vitro Toxicity Testing Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe In-Vitro Toxicity Testing Revenue by Company (2021-2024)
7.2 Europe In-Vitro Toxicity Testing Revenue by Type (2018-2034)
7.3 Europe In-Vitro Toxicity Testing Revenue by Application (2018-2034)
7.4 Europe In-Vitro Toxicity Testing Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific In-Vitro Toxicity Testing Revenue by Company (2021-2024)
8.2 Asia Pacific In-Vitro Toxicity Testing Revenue by Type (2018-2034)
8.3 Asia Pacific In-Vitro Toxicity Testing Revenue by Application (2018-2034)
8.4 Asia Pacific In-Vitro Toxicity Testing Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America In-Vitro Toxicity Testing Revenue by Company (2021-2024)
9.2 Latin America In-Vitro Toxicity Testing Revenue by Type (2018-2034)
9.3 Latin America In-Vitro Toxicity Testing Revenue by Application (2018-2034)
9.4 Latin America In-Vitro Toxicity Testing Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa In-Vitro Toxicity Testing Revenue by Company (2021-2024)
10.2 Middle East and Africa In-Vitro Toxicity Testing Revenue by Type (2018-2034)
10.3 Middle East and Africa In-Vitro Toxicity Testing Revenue by Application (2018-2034)
10.4 Middle East and Africa In-Vitro Toxicity Testing Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In-Vitro Toxicity Testing Products and Services
11.1.4 Thermo Fisher Scientific In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.1.5 Thermo Fisher Scientific In-Vitro Toxicity Testing SWOT Analysis
11.1.6 Thermo Fisher Scientific Recent Development
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance In-Vitro Toxicity Testing Products and Services
11.2.4 Covance In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.2.5 Covance In-Vitro Toxicity Testing SWOT Analysis
11.2.6 Covance Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories In-Vitro Toxicity Testing Products and Services
11.3.4 Bio-Rad Laboratories In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.3.5 Bio-Rad Laboratories In-Vitro Toxicity Testing SWOT Analysis
11.3.6 Bio-Rad Laboratories Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare In-Vitro Toxicity Testing Products and Services
11.4.4 GE Healthcare In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.4.5 GE Healthcare In-Vitro Toxicity Testing SWOT Analysis
11.4.6 GE Healthcare Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific In-Vitro Toxicity Testing Products and Services
11.5.4 Eurofins Scientific In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.5.5 Eurofins Scientific In-Vitro Toxicity Testing SWOT Analysis
11.5.6 Eurofins Scientific Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA In-Vitro Toxicity Testing Products and Services
11.6.4 Merck KGaA In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.6.5 Merck KGaA In-Vitro Toxicity Testing SWOT Analysis
11.6.6 Merck KGaA Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Details
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories In-Vitro Toxicity Testing Products and Services
11.7.4 Charles River Laboratories In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.7.5 Charles River Laboratories In-Vitro Toxicity Testing SWOT Analysis
11.7.6 Charles River Laboratories Recent Development
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent In-Vitro Toxicity Testing Products and Services
11.8.4 Catalent In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.8.5 Catalent In-Vitro Toxicity Testing SWOT Analysis
11.8.6 Catalent Recent Development
11.9 Cyprotex
11.9.1 Cyprotex Company Details
11.9.2 Cyprotex Business Overview
11.9.3 Cyprotex In-Vitro Toxicity Testing Products and Services
11.9.4 Cyprotex In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.9.5 Cyprotex In-Vitro Toxicity Testing SWOT Analysis
11.9.6 Cyprotex Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN In-Vitro Toxicity Testing Products and Services
11.10.4 QIAGEN In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.10.5 QIAGEN In-Vitro Toxicity Testing SWOT Analysis
11.10.6 QIAGEN Recent Development
11.11 Promega
11.11.1 Promega Company Details
11.11.2 Promega Business Overview
11.11.3 Promega In-Vitro Toxicity Testing Products and Services
11.11.4 Promega In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.11.5 Promega Recent Development
11.12 Gentronix
11.12.1 Gentronix Company Details
11.12.2 Gentronix Business Overview
11.12.3 Gentronix In-Vitro Toxicity Testing Products and Services
11.12.4 Gentronix In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.12.5 Gentronix Recent Development
11.13 BioIVT
11.13.1 BioIVT Company Details
11.13.2 BioIVT Business Overview
11.13.3 BioIVT In-Vitro Toxicity Testing Products and Services
11.13.4 BioIVT In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.13.5 BioIVT Recent Development
11.14 MB Research Laboratories
11.14.1 MB Research Laboratories Company Details
11.14.2 MB Research Laboratories Business Overview
11.14.3 MB Research Laboratories In-Vitro Toxicity Testing Products and Services
11.14.4 MB Research Laboratories In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024)
11.14.5 MB Research Laboratories Recent Development
12 In-Vitro Toxicity Testing Market Dynamics
12.1 In-Vitro Toxicity Testing Industry Trends
12.2 In-Vitro Toxicity Testing Market Drivers
12.3 In-Vitro Toxicity Testing Market Challenges
12.4 In-Vitro Toxicity Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global In-Vitro Toxicity Testing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Cell Culture Technologies
Table 3. Key Players of High-throughput Technologies
Table 4. Key Players of Toxicogenomics
Table 5. Global In-Vitro Toxicity Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global In-Vitro Toxicity Testing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 7. Global In-Vitro Toxicity Testing Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global In-Vitro Toxicity Testing Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 9. Global In-Vitro Toxicity Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 10. Global In-Vitro Toxicity Testing Revenue by Players (2018-2024) & (US$ Million)
Table 11. Global In-Vitro Toxicity Testing Market Share by Players (2018-2024)
Table 12. Global Top In-Vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicity Testing as of 2022)
Table 13. Ranking of Global Top In-Vitro Toxicity Testing Companies by Revenue (US$ Million) in 2022
Table 14. Global 5 Largest Players Market Share by In-Vitro Toxicity Testing Revenue (CR5 and HHI) & (2018-2024)
Table 15. Global Key Players of In-Vitro Toxicity Testing, Headquarters and Area Served
Table 16. Global Key Players of In-Vitro Toxicity Testing, Product and Application
Table 17. Global Key Players of In-Vitro Toxicity Testing, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global In-Vitro Toxicity Testing Market Size by Type (2018-2024) & (US$ Million)
Table 20. Global In-Vitro Toxicity Testing Revenue Market Share by Type (2018-2024)
Table 21. Global In-Vitro Toxicity Testing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 22. Global In-Vitro Toxicity Testing Revenue Market Share by Type (2024-2034)
Table 23. Global In-Vitro Toxicity Testing Market Size by Application (2018-2024) & (US$ Million)
Table 24. Global In-Vitro Toxicity Testing Revenue Market Share by Application (2018-2024)
Table 25. Global In-Vitro Toxicity Testing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 26. Global In-Vitro Toxicity Testing Revenue Market Share by Application (2024-2034)
Table 27. North America In-Vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 28. North America In-Vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 29. North America In-Vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 30. North America In-Vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 31. North America In-Vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 32. North America In-Vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America In-Vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 34. North America In-Vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 35. Europe In-Vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 36. Europe In-Vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 37. Europe In-Vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 38. Europe In-Vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 39. Europe In-Vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 40. Europe In-Vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 41. Europe In-Vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 42. Europe In-Vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 43. Asia Pacific In-Vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 44. Asia Pacific In-Vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 45. Asia Pacific In-Vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 46. Asia Pacific In-Vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 47. Asia Pacific In-Vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 48. Asia-Pacific In-Vitro Toxicity Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 49. Asia Pacific In-Vitro Toxicity Testing Revenue by Region (2018-2024) & (US$ Million)
Table 50. Asia Pacific In-Vitro Toxicity Testing Revenue by Region (2024-2034) & (US$ Million)
Table 51. Latin America In-Vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 52. Latin America In-Vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 53. Latin America In-Vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 54. Latin America In-Vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 55. Latin America In-Vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 56. Latin America In-Vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 57. Latin America In-Vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 58. Latin America In-Vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 59. Middle East and Africa In-Vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 60. Middle East and Africa In-Vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 61. Middle East and Africa In-Vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 62. Middle East and Africa In-Vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 63. Middle East and Africa In-Vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 64. Middle East and Africa In-Vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 65. Middle East and Africa In-Vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 66. Middle East and Africa In-Vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific In-Vitro Toxicity Testing Product and Services
Table 70. Thermo Fisher Scientific In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 71. Thermo Fisher Scientific In-Vitro Toxicity Testing SWOT Analysis
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Covance Company Details
Table 74. Covance Business Overview
Table 75. Covance In-Vitro Toxicity Testing Product and Services
Table 76. Covance In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 77. Covance In-Vitro Toxicity Testing SWOT Analysis
Table 78. Covance Recent Development
Table 79. Bio-Rad Laboratories Company Details
Table 80. Bio-Rad Laboratories Business Overview
Table 81. Bio-Rad Laboratories In-Vitro Toxicity Testing Product and Services
Table 82. Bio-Rad Laboratories In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 83. Bio-Rad Laboratories In-Vitro Toxicity Testing SWOT Analysis
Table 84. Bio-Rad Laboratories Recent Development
Table 85. GE Healthcare Company Details
Table 86. GE Healthcare Business Overview
Table 87. GE Healthcare In-Vitro Toxicity Testing Product and Services
Table 88. GE Healthcare In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 89. GE Healthcare In-Vitro Toxicity Testing SWOT Analysis
Table 90. GE Healthcare Recent Development
Table 91. Eurofins Scientific Company Details
Table 92. Eurofins Scientific Business Overview
Table 93. Eurofins Scientific In-Vitro Toxicity Testing Product and Services
Table 94. Eurofins Scientific In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 95. Eurofins Scientific In-Vitro Toxicity Testing SWOT Analysis
Table 96. Eurofins Scientific Recent Development
Table 97. Merck KGaA Company Details
Table 98. Merck KGaA Business Overview
Table 99. Merck KGaA In-Vitro Toxicity Testing Product and Services
Table 100. Merck KGaA In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 101. Merck KGaA In-Vitro Toxicity Testing SWOT Analysis
Table 102. Merck KGaA Recent Development
Table 103. Charles River Laboratories Company Details
Table 104. Charles River Laboratories Business Overview
Table 105. Charles River Laboratories In-Vitro Toxicity Testing Product and Services
Table 106. Charles River Laboratories In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 107. Charles River Laboratories In-Vitro Toxicity Testing SWOT Analysis
Table 108. Charles River Laboratories Recent Development
Table 109. Catalent Company Details
Table 110. Catalent Business Overview
Table 111. Catalent In-Vitro Toxicity Testing Product and Services
Table 112. Catalent In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 113. Catalent In-Vitro Toxicity Testing SWOT Analysis
Table 114. Catalent Recent Development
Table 115. Cyprotex Company Details
Table 116. Cyprotex Business Overview
Table 117. Cyprotex In-Vitro Toxicity Testing Product and Services
Table 118. Cyprotex In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 119. Cyprotex In-Vitro Toxicity Testing SWOT Analysis
Table 120. Cyprotex Recent Development
Table 121. QIAGEN Company Details
Table 122. QIAGEN Business Overview
Table 123. QIAGEN In-Vitro Toxicity Testing Product and Services
Table 124. QIAGEN In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 125. QIAGEN In-Vitro Toxicity Testing SWOT Analysis
Table 126. QIAGEN Recent Development
Table 127. Promega Company Details
Table 128. Promega Business Overview
Table 129. Promega In-Vitro Toxicity Testing Product and Services
Table 130. Promega In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 131. Promega Recent Development
Table 132. Gentronix Company Details
Table 133. Gentronix Business Overview
Table 134. Gentronix In-Vitro Toxicity Testing Product and Services
Table 135. Gentronix In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 136. Gentronix Recent Development
Table 137. BioIVT Company Details
Table 138. BioIVT Business Overview
Table 139. BioIVT In-Vitro Toxicity Testing Product and Services
Table 140. BioIVT In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 141. BioIVT Recent Development
Table 142. MB Research Laboratories Company Details
Table 143. MB Research Laboratories Business Overview
Table 144. MB Research Laboratories In-Vitro Toxicity Testing Product and Services
Table 145. MB Research Laboratories In-Vitro Toxicity Testing Revenue in In-Vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 146. MB Research Laboratories Recent Development
Table 147. In-Vitro Toxicity Testing Market Trends
Table 148. In-Vitro Toxicity Testing Market Drivers
Table 149. In-Vitro Toxicity Testing Market Challenges
Table 150. In-Vitro Toxicity Testing Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. In-Vitro Toxicity Testing Product Picture
Figure 2. Global In-Vitro Toxicity Testing Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global In-Vitro Toxicity Testing Market Share by Type: 2022 VS 2034
Figure 4. Cell Culture Technologies Features
Figure 5. High-throughput Technologies Features
Figure 6. Toxicogenomics Features
Figure 7. Global In-Vitro Toxicity Testing Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 8. Global In-Vitro Toxicity Testing Market Share by Application: 2022 VS 2034
Figure 9. Pharmaceuticals & Biopharmaceuticals
Figure 10. Cosmetic & Household Products
Figure 11. Food
Figure 12. Chemicals
Figure 13. In-Vitro Toxicity Testing Report Years Considered
Figure 14. Global In-Vitro Toxicity Testing Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global In-Vitro Toxicity Testing Market Size 2018-2034 (US$ Million)
Figure 16. Global In-Vitro Toxicity Testing Market Size Market Share by Region: 2022 VS 2034
Figure 17. Global In-Vitro Toxicity Testing Revenue Market Share by Region in 2018 VS 2022
Figure 18. Global In-Vitro Toxicity Testing Revenue Market Share Forecast by Region (2024-2034)
Figure 19. Global Top 10 In-Vitro Toxicity Testing Countries Ranking by Market Size (US$ Million) in 2022
Figure 20. Global In-Vitro Toxicity Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 21. Global In-Vitro Toxicity Testing Market Share by Players in 2022
Figure 22. Global Top In-Vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicity Testing as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by In-Vitro Toxicity Testing Revenue in 2022
Figure 24. North America In-Vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 25. North America In-Vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 26. North America In-Vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 27. North America In-Vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 28. U.S. In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 29. Canada In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 30. Europe In-Vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 31. Europe In-Vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 32. Europe In-Vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 33. Europe In-Vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 34. Germany In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 35. France In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 36. U.K. In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 37. Italy In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 38. Russia In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 39. Asia Pacific In-Vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 40. Asia Pacific In-Vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 41. Asia Pacific In-Vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 42. Asia Pacific In-Vitro Toxicity Testing Revenue Share by Region (2018-2034)
Figure 43. China In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 44. Japan In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 45. South Korea In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 46. India In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 47. Australia In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 48. Taiwan In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 49. Indonesia In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 50. Thailand In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 51. Malaysia In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 52. Philippines In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 53. Vietnam In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 54. Latin America In-Vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 55. Latin America In-Vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 56. Latin America In-Vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 57. Latin America In-Vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 58. Mexico In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 59. Brazil In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 60. Argentina In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 61. Middle East and Africa In-Vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 62. Middle East and Africa In-Vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 63. Middle East and Africa In-Vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 64. Middle East and Africa In-Vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 65. Turkey In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 66. Saudi Arabia In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 67. U.A.E In-Vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 68. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 69. Covance Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 70. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 71. GE Healthcare Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 72. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 73. Merck KGaA Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 74. Charles River Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 75. Catalent Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 76. Cyprotex Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 77. QIAGEN Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 78. Promega Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 79. Gentronix Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 80. BioIVT Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 81. MB Research Laboratories Revenue Growth Rate in In-Vitro Toxicity Testing Business (2018-2024)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries